FDAClass IIJanuary 18, 2023

Rifampin Capsules recall: Impurity Out of Spec

Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-0659-07, Repackaged by…

Why was Rifampin Capsules recalled?

Failed Impurities/Degradation specifications

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #: J0599794-022322, exp. date 02/28/2023; J0621369-052622, exp. date 06/30/2023

Product
Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-0659-07, Repackaged by…
Recalling firm
RemedyRepack Inc.
Quantity
132 Cards of 30 = 3960 Tablets
Distribution
Product was distributed to one account in PA.
Recall date
January 18, 2023
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls